Vol 26, No 5 (2021)
Research paper
Published online: 2021-08-12

open access

Page views 6647
Article views/downloads 526
Get Citation

Connect on Social Media

Connect on Social Media

Complications after breast reconstruction with alloplastic material in breast cancer patients submitted or not to post mastectomy radiotherapy

Silvia Radwanski Stuart1, Alexandre Mendonça Munhoz2, Cristiane L.G. Chaves3, Eduardo Montag2, Thalita C.S Cordeiro1, Tatiana Taba Fuzisaki1, Gustavo N. Marta1, Heloisa A. Carvalho12
Rep Pract Oncol Radiother 2021;26(5):730-739.

Abstract

Background and purpose: Breast reconstruction following mastectomy is a relevant element of breast cancer treatment. The purpose of this study was to evaluate the influence of radiotherapy (RT) on local complications in patients with breast cancer that had undergone breast reconstruction with alloplastic material.

Materials and methods: Retrospective study of breast cancer patients submitted to mastectomy and breast reconstruction from 2009 to 2013. Clinical and treatment variables were correlated with early and late complications.

Results: 251 patients were included; mean age was 49.7 (25 to 78) years. Reconstruction was immediate in 94% of the patients, with 88% performed with a temporary tissue expander. Postoperative radiotherapy (RT) was delivered to 167 patients (66.5%). Early complications were present in 26.3% of the patients. Irradiated patients presented 5.4% incidence of late complications versus 2.4% for non-irradiated patients (p = 0.327). Diabetes (OR = 3.41 95% CI: 1.23–9.45, p = 0.018) and high body mass index (BMI) (OR = 2.65; 95% CI: 1.60–4.37, p < 0.0001) were the main risk factors. The overall incidence of late complications was 4.4%, with predominance of severe capsular contracture (8/11). Arterial hypertension (OR = 4.78; 95% CI: 1.97–11.63, p = 0.001), BMI (OR = 0.170; 95% CI: 0.048–0.607, p = 0.006) and implant placement (OR = 3.55; 95% CI: 1.26–9.99, p = 0.016) were related to late complications.

Conclusions: The overall rate of complications was low in this population. Radiotherapy delivery translated into a higher but not statistically significant risk of late complications when compared with the non-irradiated patients. Already well-known clinical risk factors for complications after breast reconstruction were identified.

Article available in PDF format

View PDF Download PDF file

References

  1. Darby S, McGale P, Correa C. Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011; 378(9804): 1707–1716.
  2. McGale P, Taylor C, Correa C. Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383(9935): 2127–2135.
  3. Cameron D, Piccart-Gebhart MJ, Gelber RD, et al. Herceptin Adjuvant (HERA) Trial Study Team. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet. 2017; 389(10075): 1195–1205.
  4. Haviland JS, Owen JR, Dewar JA, et al. START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013; 14(11): 1086–1094.
  5. Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015; 51(4): 451–463.
  6. Munhoz AM, Montag E, Filassi JR, et al. Immediate nipple-areola-sparing mastectomy reconstruction: An update on oncological and reconstruction techniques. World J Clin Oncol. 2014; 5(3): 478–494.
  7. Munhoz AM, Montag E, Gemperli R. Oncoplastic breast surgery: indications, techniques and perspectives. Gland Surg. 2013; 2(3): 143–157.
  8. American Society of Plastic Surgeons. 2018 National Plastic Surgery Statistics: Cosmetic and Reconstructive Procedure Trends. Arlington Heights, IL. https://www.plasticsurgery.org/documents/News/Statistics/2018/reconstructive-procedure-trends-2018.pdf (July 1st, 2020).
  9. Alderman A, Gutowski K, Ahuja A, et al. Postmastectomy ExpanderImplant Breast Reconstruction Guideline Work Group. ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg. 2014; 134(4): 648e–655e.
  10. Checketts JX, Gordon J, Crawford JH, et al. Is the Right Research Being Conducted to Advance Knowledge about Breast Reconstruction? An Analysis of the Research Pipeline. Plast Reconstr Surg. 2018; 141(3): 566–577.
  11. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16): 1233–1241.
  12. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005; 28(3): 289–294.
  13. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992; 10(6): 976–983.
  14. Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer. 2000; 36(15): 1938–1943.
  15. Carlson RW, Allred DC, Anderson BO, et al. NCCN Breast Cancer Clinical Practice Guidelines Panel. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2009; 7(2): 122–192.
  16. Agarwal S, Kidwell KM, Farberg A, et al. Immediate Reconstruction of the Radiated Breast: Recent Trends Contrary to Traditional Standards. Ann Surg Oncol. 2015; 22(8): 2551–2559.
  17. Razdan SN, Cordeiro PG, Albornoz CR, et al. National Breast Reconstruction Utilization in the Setting of Postmastectomy Radiotherapy. J Reconstr Microsurg. 2017; 33(5): 312–317.
  18. Salvo N, Barnes E, van Draanen J, et al. Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol. 2010; 17(4): 94–112.
  19. El-Sabawi B, Carey JN, Hagopian TM, et al. Radiation and breast reconstruction: Algorithmic approach and evidence-based outcomes. J Surg Oncol. 2016; 113(8): 906–912.
  20. Bentzen S, Thames H, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol. 1989; 15(3): 267–274.
  21. Sobti N, Weitzman RE, Nealon KP, et al. Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction. Sci Rep. 2020; 10(1): 1137.
  22. Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: a systematic review. Plast Reconstr Surg. 2013; 132(3): 511–518.
  23. Ascherman JA, Hanasono MM, Newman MI, et al. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg. 2006; 117(2): 359–365.
  24. Breast cancer atlas for radiation therapy planning: consensus definitions. http://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx (October 24, 2011).
  25. Evans G, Schusterman M, Kroll S, et al. Reconstruction and the Radiated Breast. Plastic and Reconstructive Surgery. 1995; 96(5): 1111–1115.
  26. Forman DL, Chiu J, Restifo RJ, et al. Breast reconstruction in previously irradiated patients using tissue expanders and implants: a potentially unfavorable result. Ann Plast Surg. 1998; 40(4): 360–3; discussion 363.
  27. Eriksson M, Anveden L, Celebioglu F, et al. Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort. Breast Cancer Res Treat. 2013; 142(3): 591–601.
  28. Frey JD, Choi M, Karp NS, et al. The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Healing after Nipple-Sparing Mastectomy. Plast Reconstr Surg. 2017; 139(1): 10e–19e.
  29. Theocharidis V, Katsaros I, Sgouromallis E, et al. Current evidence on the role of smoking in plastic surgery elective procedures: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2018; 71(5): 624–636.
  30. Matsumoto WK, Munhoz AM, Okada A, et al. Influence of advanced age on postoperative outcomes and total loss following breast reconstruction: a critical assessment of 560 cases. Rev Col Bras Cir. 2018; 45(2): e1616.
  31. Peled AW, Foster RD, Esserman LJ, et al. Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure. Plast Reconstr Surg. 2012; 130(3): 503–509.
  32. Ricci JA, Epstein S, Momoh AO, et al. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res. 2017; 218: 108–116.
  33. Naoum GE, Salama L, Niemierko A, et al. Single Stage Direct-to-Implant Breast Reconstruction Has Lower Complication Rates Than Tissue Expander and Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys. 2020; 106(3): 514–524.
  34. Jugenburg M, Disa JJ, Pusic AL, et al. Impact of radiotherapy on breast reconstruction. Clin Plast Surg. 2007; 34(1): 29–37; abstract v.
  35. Momoh AO, Ahmed R, Kelley BP, et al. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Ann Surg Oncol. 2014; 21(1): 118–124.
  36. Purcell Jackson G, Tarpley JL. How long does it take to train a surgeon? BMJ. 2009; 339: b4260.